Home
COLL
COLL News

Latest Collegium Pharmaceutical Inc. (COLL) News on April 26, 2025

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswire

2 days ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Zacks

3 days ago

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Argus Research

4 days ago

COLL: What does Argus have to say about COLL?

Argus Research

11 days ago

COLL: Raising target price to $28.00

2 Reasons to Watch COLL and 1 to Stay Cautious

StockStory

12 days ago

2 Reasons to Watch COLL and 1 to Stay Cautious

Argus Research

18 days ago

COLL: Lowering target price to $27.00

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average?

Simply Wall St.

24 days ago

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average?

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

StockStory

24 days ago

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

Argus Research

25 days ago

COLL: Lowering target price to $31.00

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

25 days ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

GlobeNewswire

a month ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

GlobeNewswire

a month ago

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Argus Research

a month ago

COLL: Raising target price to $32.00

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory

a month ago

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

a month ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

GlobeNewswire

a month ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

MT Newswires

a month ago

Collegium Pharmaceutical Insider Sold Shares Worth $313,413, According to a Recent SEC Filing

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

GlobeNewswire

2 months ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Collegium Pharmaceutical's (NASDAQ:COLL) Solid Earnings Are Supported By Other Strong Factors

Simply Wall St.

2 months ago

Collegium Pharmaceutical's (NASDAQ:COLL) Solid Earnings Are Supported By Other Strong Factors

Argus Research

2 months ago

COLL: Lowering target price to $29.00

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire

2 months ago

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

2 months ago

Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations

Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today?

Simply Wall St.

2 months ago

Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today?

Is Collegium Pharmaceutical, Inc. (COLL) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey

2 months ago

Is Collegium Pharmaceutical, Inc. (COLL) the Best Small Cap Pharma Stocks to Buy Now?

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Collegium Pharmaceutical Inc Earnings Call

GuruFocus.com

2 months ago

Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

2 months ago

Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates

Zacks

2 months ago

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates

Associated Press Finance

2 months ago

Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

StockStory

2 months ago

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

GlobeNewswire

2 months ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks

2 months ago

Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

StockStory

2 months ago

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

GuruFocus.com

2 months ago

What To Expect From Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings

Argus Research

2 months ago

COLL: Lowering target price to $30.00

Argus Research

2 months ago

COLL: Lowering target price to $31.00

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

GlobeNewswire

2 months ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Collegium Appoints Nancy S. Lurker to its Board of Directors

GlobeNewswire

3 months ago

Collegium Appoints Nancy S. Lurker to its Board of Directors

Argus Research

3 months ago

COLL: Lowering target price to $32.00

Argus Research

3 months ago

COLL: Lowering target price to $34.00

Argus Research

3 months ago

COLL: What does Argus have to say about COLL?

MT Newswires

3 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $908,628, According to a Recent SEC Filing

MT Newswires

4 months ago

Needham Upgrades Collegium Pharmaceutical to Buy From Hold, Price Target is $46

Collegium Pharmaceutical Unveils 2025 Financial Projections

TipRanks

4 months ago

Collegium Pharmaceutical Unveils 2025 Financial Projections

MT Newswires

4 months ago

Collegium Pharmaceutical Shares Rise After 2025 Guidance

Collegium Provides 2025 Financial Guidance and Business Update

GlobeNewswire

4 months ago

Collegium Provides 2025 Financial Guidance and Business Update

Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus

Simply Wall St.

4 months ago

Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus

Argus Research

4 months ago

COLL: Lowering target price to $31.00

Argus Research

4 months ago

COLL: What does Argus have to say about COLL?

Argus Research

5 months ago

COLL: What does Argus have to say about COLL?

Argus Research

5 months ago

COLL: Lowering target price to $32.00

Argus Research

5 months ago

COLL: Raising target price to $33.00

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest

Simply Wall St.

5 months ago

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

Zacks

5 months ago

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

Argus Research

5 months ago

COLL: Lowering target price to $33.00

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire

5 months ago

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

GuruFocus.com

6 months ago

Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Zacks

6 months ago

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

Zacks

6 months ago

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

Zacks

6 months ago

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

Associated Press Finance

6 months ago

Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Reports Record Third Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Collegium Reports Record Third Quarter 2024 Financial Results

Collegium Appoints Vikram Karnani as Chief Executive Officer

GlobeNewswire

6 months ago

Collegium Appoints Vikram Karnani as Chief Executive Officer

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings

GuruFocus.com

6 months ago

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings

Argus Research

6 months ago

COLL: Lowering target price to $35.00

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

6 months ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?

Zacks

6 months ago

Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Zacks

6 months ago

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

GlobeNewswire

6 months ago

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

Zacks

7 months ago

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

GuruFocus.com

7 months ago

Collegium Pharmaceutical Inc (COLL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Argus Research

7 months ago

COLL: Lowering target price to $40.00

Breakouts Boost These Three Stocks To All-Time Highs

Investor's Business Daily

7 months ago

Breakouts Boost These Three Stocks To All-Time Highs

Should We Be Delighted With Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 46%?

Simply Wall St.

7 months ago

Should We Be Delighted With Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 46%?

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Zacks

7 months ago

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?

Zacks

7 months ago

Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?

Collegium Pharmaceutical (COLL) Upgraded to Buy: Here's Why

Zacks

8 months ago

Collegium Pharmaceutical (COLL) Upgraded to Buy: Here's Why

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Zacks

8 months ago

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...

GuruFocus.com

8 months ago

Insider Sale: EVP and General Counsel Shirley Kuhlmann Sells 20,225 Shares of Collegium ...

MT Newswires

8 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $773,792, According to a Recent SEC Filing

MT Newswires

8 months ago

Collegium Closes Acquisition of Ironshore Therapeutics; Boosts 2024 Product Revenue

Collegium Completes Acquisition of Ironshore Therapeutics

GlobeNewswire

8 months ago

Collegium Completes Acquisition of Ironshore Therapeutics

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

8 months ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024

GlobeNewswire

8 months ago

Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024

Argus Research

8 months ago

COLL: Raising target price to $40.00

Argus Research

8 months ago

COLL: Raising target price to $38.00

Shareholders Will Be Pleased With The Quality of Collegium Pharmaceutical's (NASDAQ:COLL) Earnings

Simply Wall St.

8 months ago

Shareholders Will Be Pleased With The Quality of Collegium Pharmaceutical's (NASDAQ:COLL) Earnings

Collegium Pharmaceutical (COLL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

9 months ago

Collegium Pharmaceutical (COLL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates

Zacks

9 months ago

Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates

Associated Press Finance

9 months ago

Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Reports Second Quarter 2024 Financial Results

GlobeNewswire

9 months ago

Collegium Reports Second Quarter 2024 Financial Results

Unveiling Collegium Pharmaceutical (COLL) Q2 Outlook: Wall Street Estimates for Key Metrics

Zacks

9 months ago

Unveiling Collegium Pharmaceutical (COLL) Q2 Outlook: Wall Street Estimates for Key Metrics

Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

9 months ago

Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?

Zacks

9 months ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?

Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?

Zacks

9 months ago

Collegium Pharmaceutical (COLL) Soars 10.6%: Is Further Upside Left in the Stock?

Collegium buys Ironshore for $525m and enter ADHD market

Pharmaceutical Technology

9 months ago

Collegium buys Ironshore for $525m and enter ADHD market

MT Newswires

9 months ago

Collegium Pharmaceutical to Acquire Ironshore Therapeutics for $525 Million

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

GlobeNewswire

9 months ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire

9 months ago

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

Share on Social Networks: